QIAGEN N.V.
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Thierry Bernard is the company's Chief Executive Officer (CEO).
Basic company information
Each field links to its source. Financial figures retain their reporting periods; background references are identified in the source list.
- Business sectors
- biotechnology [1]
- Company / filing name
- QIAGEN N.V. [2]
- Headquarters location
- Venlo [1]
- Founded
- 1984 [1]
- Legal form
- naamloze vennootschap [1]
- Official website
- www.qiagen.com ↗ [1]
- Employees
- 4,910 · reported year 2023 [1]
- ISIN (reported securities)
- NL0000240000 [1]
- CIK
- 1015820 [2]
- Country in background record
- Netherlands [1]
- Symbols / exchanges
- QGEN (NYSE) [2]
Company positioning and business
QIAGEN N.V. is a German-founded multinational provider of sample and assay technologies for molecular diagnostics, applied testing, academic research, and pharmaceutical research. The company operates in more than 35 offices in over 25 countries. QIAGEN N.V., the global corporate headquarter of the QIAGEN group, is located in Venlo, The Netherlands. The main operative headquarters are located in Hilden, Germany. European, American, Chinese, and Asian-Pacific regional headquarters are located respectively in Hilden, Germany; Germantown, Maryland, United States; Shanghai, China; and Singapore. QIAGEN's shares are listed at the NYSE (using ticker QGEN) and at the Frankfurt Stock Exchange in the Prime Standard (using ticker QIA). Thierry Bernard is the company's Chief Executive Officer (CEO). [3]
Background text: Wikipedia contributors, Qiagen. Selected introductory paragraphs, licensed under CC BY-SA 4.0. Official filing data is cited separately.
Understanding company scale
Employees: 4,910 · reported year 2023. [1]
Financial year, securities and disclosures
Listed securities: QGEN (NYSE). Multiple symbols may represent different share classes or securities of the same registrant. [2]
History and key events
Founding / inception date recorded in Wikidata. [1]
Financial results and regulatory disclosures
No individual financial documents have been indexed yet. Open the source to consult company disclosures. [2]
Related entities and concepts
Frequently asked questions
When was QIAGEN N.V. founded?
Founded: 1984. The linked source provides the background record. [1]
Where is the headquarters of QIAGEN N.V.?
Headquarters location: Venlo. The linked source provides the background record. [1]
Which business sectors are recorded for QIAGEN N.V.?
Business sectors: biotechnology. The linked source provides the background record. [1]
Sources and review dates
- Wikidata — company background record (CC0) ↗
- Company identity and profile data ↗
- Wikipedia contributors — Qiagen (CC BY-SA 4.0) ↗
Reviewed 23 October 2026. Financial periods and historical event dates are shown separately. Figures reflect their stated source dates; this page is not a live quote or investment recommendation.